为进一步满足群众就医购药需求，长春市医保局以医保智慧服务为驱动，拓宽丰富移动支付使用内涵， 延伸打造"互联网+医保服务"新场景。2025年12月24日起，长春市职工医保参保人可直接使用医保个人 账户线上购买非处方（OTC）药品，实现医保个人账户在线支付药品费用。 为确保服务规范及医保基金使用安全，此次线上购药服务改革以省内规模最大的医药零售连锁企业吉林 大药房为试点，开通15家门店线上购药服务功能，覆盖长春市城区、开发区，方便参保人就近享受线上 医保购药服务的同时，对购药全流程实施监管。参保人只需登录吉林大药房线上平台，选择试点门店及 所需OTC药品，即可直接使用医保个人账户完成线上支付，药品由门店快速配送到家，享受"足不出户 刷医保、药品配送到家"的便捷服务。 | 12 | 吉林大药房药业股份有限公司清华园连锁店 | | --- | --- | | 13 | 吉林大药房药业股份有限公司长春兴华园连锁店 | | 14 | 吉林大药房药业股份有限公司融和嘉园连锁店 | | 15 | 吉林大药房药业股份有限公司阜丰路连锁店 | 林日报微信公众号 来源：吉 此次线上购药服务的开通，不仅打破了传统购药方式的限制，为长 ...

| 日期 | 证券代 | 证券简 质押笔 | 无限售股份质押数里 | 有限售股份质押数里 | A股总股本 | 质押比例 | | --- | --- | --- | --- | --- | --- | --- | | 唱 | | 都 载 | (万) | (万) | (万) | (%) | | 20251219 603883 | | 老自姓 8 | 23455.04 | 0.00 | 75889.02 | 30.91 | 中国经济网北京12月25日讯 老百姓（603883）(603883.SH)昨晚披露关于控股股东股票质押的公告称，公司控股股 东老百姓医药集团有限公司（以下简称"医药集团"）持有公司股份数量为180,453,475股，占公司总股本比例为 23.78%；累计质押股份数量为114,140,000股（含本次质押），占其所持股份比例为63.25%，占公司总股本比例为 15.04%。 控股股东及一致行动人（医药集团与陈秀兰）合计持有公司股份数量为194,019,173股，占公司总股本比例为 25.57%；累计质押股份数量为114,140,000股（含本次质押），占其所持股份比例为58.83%，占公司总股本比 ...

近日，叮当健康董事长杨文龙在2025年世界创新奖（WIA2025）评选中脱颖而出，荣膺"2025中国未来 健康产业创新者TOP10"。 该奖项由具有全球影响力的科技创新盛会——世界创新者年会（WIM）发起，历经多轮专家评审，从 国内外数千家候选企业与创新者中严格遴选产生，旨在表彰在各自领域展现卓越创新精神与突出发展成 就的领军人物。 此次获奖，不仅是对杨文龙个人创新领导力的高度认可，亦是对叮当健康在医药健康产业持续推动模式 变革、服务升级与生态构建的充分肯定。 在杨文龙董事长的战略引领下，叮当健康作为智能专业的医药健康服务商以及智慧健康服务直达入口， 其核心业务始终走在行业创新前沿，通过一系列突破性举措，重塑公众健康服务体验。 夯实科技基座，升级即时健康服务新基建 近年来，叮当健康持续加强数字化建设，研发、升级叮当大脑-"星垣系统"，涵盖（华北、华中、华 东、华南）四大智能仓、千寻分拣、天眼智址、MedNOW等多个子系统，显著提升运营效率。例如， 应用自助拣药扫码设备，仅需 10余秒即可完成一个订单的扫码和分拣；应用AI库存预警系统，可在流 感季、过敏季等需求密集阶段，提前做好采购筹备和实时调度。 通过智慧化 ...

Group 1 - The controlling shareholder of the company, Lao Bai Xi Medicine Group Co., Ltd., holds approximately 180 million shares, accounting for 23.78% of the total share capital [1] - The total number of pledged shares by the controlling shareholder is about 114 million, representing 63.25% of the shares held and 15.04% of the total share capital [1] - The company’s revenue composition for the first half of 2025 indicates that retail pharmacy accounts for 81.81%, franchise and alliance distribution for 17.26%, and others for 0.93% [1] Group 2 - The company's market capitalization is currently 11.6 billion yuan [2]

Core Insights - The 10th Health China Pharmaceutical Chain Development Forum was held in Taizhou, Jiangsu, focusing on industry transformation and growth opportunities under the theme "Health Marketing for Everyone" [1][3] - The forum, hosted by Yangtze River Pharmaceutical Group, has evolved over ten years from policy discussions to model innovation and now to ecological co-construction, highlighting the collaborative journey of thousands of chain partners [3] - Yangtze River Pharmaceutical's Chairman Xu Haoyu emphasized the company's commitment to building a health ecosystem through strategic capabilities and collaboration with partners, aiming to set a benchmark for industry development [3] Industry Trends - The pharmaceutical retail industry is currently undergoing a critical transformation from product sales to health service provision, with compliance, digitalization, and service orientation identified as key development directions [3] - Industry experts provided insights on data trends, consumer changes, and innovative models to help chain operations break through challenges, focusing on brand empowerment and terminal traffic conversion [3] - The forum concluded with Yangtze River Pharmaceutical's commitment to a comprehensive empowerment plan and strategic product lines to build a collaborative and win-win "He Xi Ecological Circle," addressing the industry's "increased revenue without increased profit" dilemma [3][4] Forum Objectives - The He Xi Forum serves as a high-end platform for national pharmaceutical chain enterprises to discuss hot topics, challenges, and pain points in the industry, sharing the latest development trends and exploring new models for high-quality growth [4]

证券日报网讯 12月23日，重药控股在互动平台回答投资者提问时表示，目前公司非DTP零售药房业务 正在向综合性健康管理服务平台转型，实现社区健康药房高质量发展。 （文章来源：证券日报） ...

Core Viewpoint - Dazhonglin has been recognized as a leading company in ESG practices within the pharmaceutical retail industry, marking a significant achievement in its sustainable development strategy [1][2] Group 1: Company Overview - Dazhonglin, one of China's largest chain pharmacies, had 17,385 stores as of the end of Q3 2025, including 7,029 franchise stores, with a total operating area of 887,503 square meters [1] - In the first nine months of 2025, the company added 832 new stores, continuing its strategy of expanding its presence in South China while penetrating weaker regions through self-built, acquisition, and direct franchise models [1] Group 2: ESG Practices - Dazhonglin has achieved quantifiable results in its ESG initiatives, including energy management, the use of new energy delivery vehicles, and the implementation of paperless operations, resulting in approximately 154.33 million kWh of solar power generated in 2024 and saving around 25.24 million cardboard boxes [2] - The company has engaged in community service through public donations and health management services, conducting over 40,000 health education activities and providing health monitoring services to over 1 million residents, positioning itself as a "community health service station" [2] - Dazhonglin emphasizes strong corporate governance as a foundation for sustainable development, maintaining a transparent governance structure and robust risk management, which supports its compliance and ethical business practices [2] Group 3: Future Outlook - The company's ESG practices reflect a shift from compliance management to value-driven operations, enhancing its long-term competitiveness and providing a reference for sustainable development in the industry [2] - With the growing demand for chronic disease management in an aging society, Dazhonglin's integrated approach of "medicine + pharmacy + insurance" is expected to further unlock synergies between ESG and commercial value [2]

Core Insights - The "Jiao Yang Hao Qi Se, Jiang Run Shi San Cheng" winter health event in Jiangsu, organized by Dong'e Ejiao in collaboration with Lao Bai Xing Pharmacy and Litchi News, has successfully launched in multiple cities, promoting health and wellness through traditional culture and modern interaction [1][17] Group 1: Event Overview - The event series includes six main activities and 100 sub-events across Jiangsu, with successful launches in Nanjing, Suzhou, Huai'an, Nantong, and Yangzhou [17] - The Yangzhou event featured a vibrant atmosphere with high attendance, showcasing a blend of traditional health concepts and modern engagement [1][4] Group 2: Interactive Experience - Attendees participated in an immersive health journey, collecting exclusive health Buff cards and enjoying traditional Ejiao delicacies and creative tea tastings [4][10] - The event included various interactive games and performances, enhancing the festive atmosphere and encouraging community participation [10][11] Group 3: Health Education - Health experts shared practical wellness tips, emphasizing simple dietary choices and lifestyle habits suitable for winter, such as incorporating walnuts and sesame into meals [7][8] - Professional health consultations were available, providing attendees with personalized advice and fostering a community of shared wellness experiences [7][8] Group 4: Collaborative Efforts - The event highlighted the collaboration between Dong'e Ejiao and Lao Bai Xing Pharmacy, aiming to make health and wellness more accessible and engaging for the public [17] - The launch ceremony symbolized a commitment to community health, with leaders from both organizations expressing their dedication to promoting wellness [14]

Core Viewpoint - The article highlights the illegal sale of prescription drugs by several retail pharmacies in Shizhu County, which involved renting pharmacist qualifications and resulted in a significant public health risk [1][2][3] Group 1: Illegal Activities - Multiple retail pharmacies in Shizhu County were found to be selling prescription drugs without verifying valid prescriptions, leading to potential medication errors and health risks for consumers [1] - Pharmacies engaged in practices such as retroactively entering false electronic prescriptions to evade regulatory scrutiny and allowed unqualified personnel to sign prescriptions [1] - The illegal activities not only jeopardized public health but also disrupted the regulatory order of drug sales, undermining the prescription drug management system [1] Group 2: Regulatory Response - The Shizhu County Procuratorate initiated an investigation and issued recommendations for immediate corrective actions to the local market supervision bureau, which showed some improvement in compliance [2] - Despite initial improvements, ongoing reports indicated that nine pharmacies continued to engage in illegal sales, prompting the Procuratorate to file an administrative public interest lawsuit against the market supervision bureau [2] - The court found that the market supervision bureau had not effectively monitored compliance after issuing correction orders, leading to a ruling that confirmed the bureau's failure to fulfill its legal responsibilities [3] Group 3: Implications for Public Health - The case underscores the importance of regulatory bodies in ensuring the safe sale of prescription drugs and highlights the need for effective oversight to protect public health [3] - The involvement of the judiciary in addressing regulatory failures serves as a precedent for promoting lawful administration and safeguarding the health of the populace [3]

Core Viewpoint - The article highlights the misuse of medical insurance personal accounts, where everyday products are disguised as medical devices to exploit insurance funds, threatening the integrity of healthcare financing [1][2][3]. Group 1: Misuse of Medical Insurance - Everyday items like toothbrushes and masks are being labeled as medical devices, allowing them to be sold in pharmacies and purchased with medical insurance cards [1]. - Some companies are packaging low-value daily products as "medical devices," leading to significant financial losses in medical insurance funds [2][3]. - The practice of using medical insurance cards for non-medical purchases is misleading, as these funds are intended for essential healthcare needs [3]. Group 2: Regulatory and Systemic Issues - The current regulatory framework allows for the misclassification of everyday products as medical devices, necessitating a revision of the medical device classification directory [4]. - There is a need to clarify the payment items in the medical insurance directory to ensure funds are used appropriately for medical purposes [4]. - Strengthening the governance of medical insurance funds is essential to prevent misuse and ensure that funds are directed towards genuine healthcare needs [4].